Devices & Diagnostics, Health IT, Hospitals, Startups

Startup Ischemia Care raises $1.9M for stroke detection technology

Ischemia Care, a Cincinnati-based company that combines bioinformatics and medical devices for stroke detection, is […]

Ischemia Care, a Cincinnati-based company that combines bioinformatics and medical devices for stroke detection, is in the midst of raising up to $5 million, according to a filing with the SEC. 

So far, Ischemia Care, founded in 2009, has raised $1.9 million through equity offerings, with an additional $3.1 million to be sold, according to the From D filing.

The company, headed by CEO Jeffrey June,  has developed a blood test called ISCDX, which uses gene expression profiles to distinguish differing types of strokes and where they originate. There is a significant need to figure out how and where strokes originate, the company says.

“Despite advances in imaging, cardiac monitoring and clinical examination, in 30 percent of ischemic strokes, the cause remains unknown,” it says on its website. “Cause drives clinical outcomes and there are no blood tests for cause of stroke.”

The blood test is ordered by a hospital physician after a stroke has occurred. Results are reported to the lab and then back to the physician while the patient is still hospitalized, in the hopes of identifying the origin of the stroke and finding possible prevention efforts.

Ischemia Care has led clinical trials with more than 950 patients and has formed strategic relationships with Medtronic and Affymetrix1, along with primary stroke center hospitals.

Shares0
Shares0